Drug Type Small molecule drug |
Synonyms 埃索美拉唑镁/碳酸氢钠, 海悦美奥 |
Target |
Mechanism Proton pump inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (30 Sep 2022), |
Regulation- |
Molecular FormulaCH2NaO3 |
InChIKeyWJEIYVAPNMUNIU-UHFFFAOYSA-N |
CAS Registry144-55-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Duodenal Ulcer | CN | 08 May 2024 | |
Erosive esophagitis | CN | 08 May 2024 | |
Stomach Ulcer | CN | 08 May 2024 | |
Gastroesophageal Reflux | CN | 30 Sep 2022 | |
Helicobacter pylori infection | CN | 30 Sep 2022 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Stomach Ulcer | IND Approval | CN | 16 Jul 2024 | |
Esophagitis, Peptic | IND Approval | CN | 03 Jul 2024 | |
Esophagitis, Peptic | IND Approval | CN | 03 Jul 2024 |